Total Holdings
35
Portfolio diversification across 35 positions
MEDX
(NASDAQ)Horizon Kinetics Medical ETF
$35.37-- (--)
Loading... - Market loading
MEDX ETF Holdings: Horizon Kinetics Medical ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$17.92M
Total fund assets
Expense Ratio
0.85%
Annual management fee
Fund Issuer
Horizon Kinetics
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 33 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 18.57% |
| 2 |  | AbbVie Inc. | Stock | 8.53% |
| 3 |  | Novartis AG | Stock | 7.18% |
| 4 | N NVSN.MX | Novartis AG ADR | Stock | 7.17% |
| 5 |  | Johnson & Johnson | Stock | 5.65% |
| 6 | L LSE:AZN | AstraZeneca PLC | Stock | 5.35% |
| 7 | L LON:AZN | AstraZeneca PLC | Stock | 5.00% |
| 8 |  | Alkermes plc | Stock | 4.98% |
| 9 |  | Bristol-Myers Squibb Company | Stock | 4.91% |
| 10 |  | Ionis Pharmaceuticals, Inc | Stock | 4.83% |
| 11 |  | Amgen Inc. | Stock | 4.09% |
| 12 |  | Merck & Co., Inc | Stock | 3.91% |
| 13 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.84% |
| 14 |  | Pfizer Inc | Stock | 3.53% |
| 15 |  | Biogen Inc. | Stock | 3.04% |
| 16 |  | GlaxoSmithKline plc | Stock | 2.92% |
| 17 |  | CRISPR Therapeutics AG | Stock | 2.85% |
| 18 |  | Regeneron Pharmaceuticals, Inc | Stock | 2.60% |
| 19 |  | Beam Therapeutics Inc | Stock | 1.43% |
| 20 |  | Intellia Therapeutics, Inc | Stock | 0.99% |
| 21 |  | Vanda Pharmaceuticals Inc | Stock | 0.99% |
| 22 | O OTCGREY:SDZNY | SDZNY | Stock | 0.83% |
| 23 | O OTC:SDZNY | Sandoz Group AG | Stock | 0.79% |
| 24 |  | Galectin Therapeutics Inc. | Stock | 0.70% |
| 25 |  | Haleon plc | Stock | 0.63% |
| 26 |  | Replimune Group, Inc. | Stock | 0.62% |
| 27 |  | Lantern Pharma Inc. | Stock | 0.54% |
| 28 |  | Editas Medicine, Inc | Stock | 0.50% |
| 29 |  | Bicycle Therapeutics plc | Stock | 0.36% |
| 30 |  | GE HealthCare Technologies Inc. | Stock | 0.30% |
| 31 |  | Viatris Inc | Stock | 0.29% |
| 32 |  | Allogene Therapeutics, Inc | Stock | 0.21% |
| 33 |  | Pacific Biosciences of California, Inc | Stock | 0.09% |
Frequently Asked Questions About Horizon Kinetics Medical ETF Holdings
What are the top holdings in MEDX?
Horizon Kinetics Medical ETF (MEDX) holds 35 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is MEDX's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review MEDX's holdings table to analyze concentration risk.
What is MEDX's sector allocation?
The Sector Allocation chart shows how MEDX distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does MEDX invest in?
MEDX's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is MEDX ETF?
MEDX's diversification can be assessed by reviewing its 35 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.